• Home
  • Mutual Funds
  • ITI Pharma and Healthcare Fund Growth

ITI Pharma and Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

ITI Pharma and Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹500 & Lump. ₹5000

AUM (Fund size)

₹230 Cr

Lock In Period

N/A

Expense Ratio

4.84

Exit Load

If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50%.Exit Load after completion of 3 months - Nil.

Benchmark

NIFTY Healthcare Total Return Index

Summary

ITI Pharma and Healthcare Fund Growth NAV is ₹16.8275 as of 22 May, 2026. ITI Pharma and Healthcare Fund Growth has delivered 81.37% returns since its launch. The minimum SIP investment amount in ITI Pharma and Healthcare Fund Growth is ₹500. The AUM of ITI Pharma and Healthcare Fund Growth is ₹230 Cr. The expense ratio of the fund is 4.84%, and its benchmark is NIFTY Healthcare Total Return Index. The current exit load of the fund is If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50%.Exit Load after completion of 3 months - Nil.. In the last 1M months, ITI Pharma and Healthcare Fund Growth has delivered 8.38% returns.

ITI Pharma and Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M8.38-0.4010.84
6M3.761.44107.57
1Y4.454.73199.83
3Y21.9512.37325.05

Portfolio Analysis

  • Equity: 96.88%
  • Debt: 3.12%
  • Others
As on: 2026-04-30
View allocation % by

1. Sun Pharmaceutical Industries Limited12.40%
2. Divi's Laboratories Limited8.83%
3. Torrent Pharmaceuticals Limited4.82%
4. Lupin Limited4.44%
5. Aurobindo Pharma Limited4.36%
6. Laurus Labs Limited4.24%
7. Cohance Lifesciences Limited3.08%
8. Neuland Laboratories Limited3.05%
9. Alkem Laboratories Limited2.93%
10. Glenmark Pharmaceuticals Limited2.69%
11. Mankind Pharma Limited1.91%
12. Sai Life Sciences Limited1.84%
13. Dr. Reddy's Laboratories Limited1.82%
14. Abbott India Limited1.79%
15. Cipla Limited1.64%
16. IPCA Laboratories Limited1.50%
17. FDC Limited1.21%
18. Piramal Pharma Limited1.20%
19. Biocon Limited1.19%
20. GlaxoSmithKline Pharmaceuticals Limited0.94%
21. Shilpa Medicare Limited0.88%
22. Caplin Point Laboratories Limited0.78%
23. Supriya Lifescience Limited0.77%
24. Zydus Lifesciences Limited0.65%
25. Syngene International Limited0.45%

1. Apollo Hospitals Enterprise Limited6.25%
2. Max Healthcare Institute Limited5.22%
3. Fortis Healthcare Limited3.11%
4. Aster DM Healthcare Limited2.24%
5. Park Medi World Limited1.67%
6. Healthcare Global Enterprises Limited1.09%
7. Rainbow Childrens Medicare Limited0.99%

1. Linde India Limited1.37%

1. Shaily Engineering Plastics Limited1.29%

1. Jubilant Ingrevia Limited1.28%

1. SBI Life Insurance Company Limited1.26%

About Fund ITI Pharma and Healthcare Fund Growth

ITI Pharma and Healthcare Fund Growth managed by ITI Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹230 Crore. The fund benchmarks its performance against the NIFTY Healthcare Total Return Index while maintaining an expense ratio of 4.84. Under the expert guidance of Animesh Singh ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Animesh Singh

Mr. Animesh Singh holds Post Graduate Diploma in Management, Bachelor of Honours -(Economics) CFA - USA Certification. Prior to joining the ITI AMC, he was associated with Julius Baer wealth Advisor, Centrum Wealth, Nippon Life India Asset Management Ltd, Reliance Portfolio Management Services, KSBL and SSKI Securities.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
Kotak Manufacture in India Fund Growth22669.42 CR1.98
ICICI Prudential Transportation and Logistics Fund Growth22864.45 CR2.01
ITI Pharma and Healthcare Fund Growth0229.56 CR4.84
ICICI Prudential PSU Equity Fund Growth21975.03 CR2.38
Nippon India Taiwan Equity Fund Growth31138.67 CR2.17
Fund Name1Y3Y
This FundKotak Manufacture in India Fund Growth9.708677.028
This FundICICI Prudential Transportation and Logistics Fund Growth6.83281.215
This FundITI Pharma and Healthcare Fund Growth4.445281.3687
This FundICICI Prudential PSU Equity Fund Growth6.61898.4601
This FundNippon India Taiwan Equity Fund Growth195.73307.7642

ITI Pharma and Healthcare Fund Growth FAQs

ITI Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of ITI Pharma and Healthcare Fund Growth is 4.84. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

ITI Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 8.38%
  • 6 Months : 3.76%
  • 1 Year : 4.45%
  • 3 Years : 21.95%
Returns of ITI Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ 16.8275 as on May 20,2026. Since inception, the return has been 81.37%.

You can invest in ITI Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of ITI Pharma and Healthcare Fund Growth is ₹230 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in ITI Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.